Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04420975
Title Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

synovial sarcoma

sarcoma

fibrosarcoma

spindle cell sarcoma

myxofibrosarcoma

liposarcoma

retroperitoneal sarcoma

malignant fibrous histiocytoma

leiomyosarcoma

Therapies

BO-112 + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.